United States Prostate Cancer Drugs Market Report 2018

January 2018 | 118 pages | ID: U082AD52060EN
QYResearch

Abstracts

In this report, the United States Prostate Cancer Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Prostate Cancer Drugs in these regions, from 2013 to 2025 (forecast).

United States Prostate Cancer Drugs market competition by top manufacturers/players, with Prostate Cancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Astellas Pharma
• Astra Zeneca
• Johnson & Johnson
• Sanofi
• GlaxoSmithKline
• Merck Group
• Novartis
• Amgen
• Bayer HealthCare
• Ferring Pharmaceutical
• Janssen Pharmaceuticals
• Endo Pharmaceuticals
• BMS
• Takeda Pharmaceuticals
• Northwest Biotherapeutics
• Teva Pharmaceutical
• Boehringer Ingelheim
• Foresee Pharmaceuticals
• Tokai Pharmaceuticals
• Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinics
• Hospitals
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Prostate Cancer Drugs Market Report 2018

1 PROSTATE CANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs by Product Category
  1.2.1 United States Prostate Cancer Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Prostate Cancer Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Hormonal Therapy
  1.2.4 Chemotherapy
  1.2.5 Immunotherapy
  1.2.6 Targeted Therapy
1.3 United States Prostate Cancer Drugs Market by Application/End Users
  1.3.1 United States Prostate Cancer Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinics
  1.3.3 Hospitals
  1.3.4 Other
1.4 United States Prostate Cancer Drugs Market by Region
  1.4.1 United States Prostate Cancer Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Prostate Cancer Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Prostate Cancer Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Prostate Cancer Drugs Status and Prospect (2013-2025)
  1.4.5 New England Prostate Cancer Drugs Status and Prospect (2013-2025)
  1.4.6 The South Prostate Cancer Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Prostate Cancer Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Prostate Cancer Drugs (2013-2025)
  1.5.1 United States Prostate Cancer Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Prostate Cancer Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES PROSTATE CANCER DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Prostate Cancer Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Prostate Cancer Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Prostate Cancer Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Prostate Cancer Drugs Market Competitive Situation and Trends
  2.4.1 United States Prostate Cancer Drugs Market Concentration Rate
  2.4.2 United States Prostate Cancer Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Prostate Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PROSTATE CANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Prostate Cancer Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Prostate Cancer Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Prostate Cancer Drugs Price by Region (2013-2018)

4 UNITED STATES PROSTATE CANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Prostate Cancer Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Prostate Cancer Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Prostate Cancer Drugs Price by Type (2013-2018)
4.4 United States Prostate Cancer Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PROSTATE CANCER DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Prostate Cancer Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Prostate Cancer Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROSTATE CANCER DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Astellas Pharma
  6.2.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Astra Zeneca
  6.3.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Merck Group
  6.7.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Novartis
  6.8.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Amgen
  6.9.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Bayer HealthCare
  6.10.2 Prostate Cancer Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Ferring Pharmaceutical
6.12 Janssen Pharmaceuticals
6.13 Endo Pharmaceuticals
6.14 BMS
6.15 Takeda Pharmaceuticals
6.16 Northwest Biotherapeutics
6.17 Teva Pharmaceutical
6.18 Boehringer Ingelheim
6.19 Foresee Pharmaceuticals
6.20 Tokai Pharmaceuticals
6.21 Spectrum Pharmaceuticals

7 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

7.1 Prostate Cancer Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostate Cancer Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostate Cancer Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROSTATE CANCER DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Prostate Cancer Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Prostate Cancer Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Prostate Cancer Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Prostate Cancer Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Cancer Drugs
Figure United States Prostate Cancer Drugs Market Size (K Pcs) by Type (2013-2025)
Figure United States Prostate Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Hormonal Therapy Product Picture
Figure Chemotherapy Product Picture
Figure Immunotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure United States Prostate Cancer Drugs Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Prostate Cancer Drugs by Application in 2017
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Prostate Cancer Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Prostate Cancer Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Prostate Cancer Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Prostate Cancer Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Prostate Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 United States Prostate Cancer Drugs Sales Share by Players/Suppliers
Figure United States Prostate Cancer Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Prostate Cancer Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Prostate Cancer Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Prostate Cancer Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Prostate Cancer Drugs Revenue Share by Players/Suppliers
Table United States Market Prostate Cancer Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Prostate Cancer Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Prostate Cancer Drugs Market Share of Top 3 Players/Suppliers
Figure United States Prostate Cancer Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Prostate Cancer Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Prostate Cancer Drugs Product Category
Table United States Prostate Cancer Drugs Sales (K Pcs) by Region (2013-2018)
Table United States Prostate Cancer Drugs Sales Share by Region (2013-2018)
Figure United States Prostate Cancer Drugs Sales Share by Region (2013-2018)
Figure United States Prostate Cancer Drugs Sales Market Share by Region in 2017
Table United States Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Prostate Cancer Drugs Revenue Share by Region (2013-2018)
Figure United States Prostate Cancer Drugs Revenue Market Share by Region (2013-2018)
Figure United States Prostate Cancer Drugs Revenue Market Share by Region in 2017
Table United States Prostate Cancer Drugs Price (USD/Pcs) by Region (2013-2018)
Table United States Prostate Cancer Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Prostate Cancer Drugs Sales Share by Type (2013-2018)
Figure United States Prostate Cancer Drugs Sales Share by Type (2013-2018)
Figure United States Prostate Cancer Drugs Sales Market Share by Type in 2017
Table United States Prostate Cancer Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Prostate Cancer Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2013-2018)
Figure Revenue Market Share of Prostate Cancer Drugs by Type in 2017
Table United States Prostate Cancer Drugs Price (USD/Pcs) by Types (2013-2018)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Type (2013-2018)
Table United States Prostate Cancer Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Prostate Cancer Drugs Sales Market Share by Application (2013-2018)
Figure United States Prostate Cancer Drugs Sales Market Share by Application (2013-2018)
Figure United States Prostate Cancer Drugs Sales Market Share by Application in 2017
Table United States Prostate Cancer Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Application (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AbbVie Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure AbbVie Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure AbbVie Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Astellas Pharma Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Astellas Pharma Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astra Zeneca Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Astra Zeneca Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Astra Zeneca Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Merck Group Basic Information List
Table Merck Group Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Group Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Merck Group Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Merck Group Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Novartis Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Novartis Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Amgen Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Amgen Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer HealthCare Prostate Cancer Drugs Sales Growth Rate (2013-2018)
Figure Bayer HealthCare Prostate Cancer Drugs Sales Market Share in United States (2013-2018)
Figure Bayer HealthCare Prostate Cancer Drugs Revenue Market Share in United States (2013-2018)
Table Ferring Pharmaceutical Basic Information List
Table Janssen Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Basic Information List
Table BMS Basic Information List
Table Takeda Pharmaceuticals Basic Information List
Table Northwest Biotherapeutics Basic Information List
Table Teva Pharmaceutical Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Foresee Pharmaceuticals Basic Information List
Table Tokai Pharmaceuticals Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Players/Suppliers in 2017
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure United States Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Prostate Cancer Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Prostate Cancer Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Prostate Cancer Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Prostate Cancer Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources